Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berends

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Experimental Dermatology|March 11, 2004
The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasisW H P M Vissers, M Berends, L Muys, et al.
The Journal of Dermatological Treatment|May 24, 2007
Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practiceMaartje A M Berends, Rieke J B Driessen, Annechien M G Langewouters, et al.
BMC Biology|November 11, 2015
Molecular insights into the surface-specific arrangement of complement C5 convertase enzymesEvelien T M Berends, Ronald D Gorham, Maartje Ruyken, et al.
Frontiers in Immunology|August 8, 2018
Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified ModelsSeline A Zwarthoff, Evelien T M Berends, Sanne Mol, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 26, 2011
Safety of treatment with biologics for psoriasis in daily practice: 5-year dataP P M van Lümig, R J B Driessen, M A M Berends, et al.
The Journal of Dermatological Treatment|January 23, 2009
Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: a pilot studyRosanne G van Lingen, Elke M G J de Jong, Maartje A M Berends, et al.
Archives of Dermatology|December 19, 2007
Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimensMaartje A M Berends, Martijn G H van Oijen, Josje Snoek, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2006
Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequentM A M Berends, J Snoek, E M G J de Jong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2007
Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosisMaartje A M Berends, Josje Snoek, Elke M G J de Jong, et al.
Journal of Innate Immunity|July 12, 2014
Novel role of the antimicrobial peptide LL-37 in the protection of neutrophil extracellular traps against degradation by bacterial nucleasesAriane Neumann, Lena Völlger, Evelien T M Berends, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Experimental Dermatology|March 11, 2004
The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasisW H P M Vissers, M Berends, L Muys, et al.
The Journal of Dermatological Treatment|May 24, 2007
Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practiceMaartje A M Berends, Rieke J B Driessen, Annechien M G Langewouters, et al.
BMC Biology|November 11, 2015
Molecular insights into the surface-specific arrangement of complement C5 convertase enzymesEvelien T M Berends, Ronald D Gorham, Maartje Ruyken, et al.
Frontiers in Immunology|August 8, 2018
Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified ModelsSeline A Zwarthoff, Evelien T M Berends, Sanne Mol, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 26, 2011
Safety of treatment with biologics for psoriasis in daily practice: 5-year dataP P M van Lümig, R J B Driessen, M A M Berends, et al.
The Journal of Dermatological Treatment|January 23, 2009
Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: a pilot studyRosanne G van Lingen, Elke M G J de Jong, Maartje A M Berends, et al.
Archives of Dermatology|December 19, 2007
Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimensMaartje A M Berends, Martijn G H van Oijen, Josje Snoek, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2006
Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequentM A M Berends, J Snoek, E M G J de Jong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2007
Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosisMaartje A M Berends, Josje Snoek, Elke M G J de Jong, et al.
Journal of Innate Immunity|July 12, 2014
Novel role of the antimicrobial peptide LL-37 in the protection of neutrophil extracellular traps against degradation by bacterial nucleasesAriane Neumann, Lena Völlger, Evelien T M Berends, et al.
Pageof 6